(Q37365418)
Statements
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up (English)
C W Lees
A I Ali
A I Thompson
L Marquez
C J Cochrane
S Aitken
J Fennell
P Rogers
A G Shand
I D Penman
K R Palmer
D C Wilson
I D R Arnott